![]() |
| Dr. Diana Do (Stanford University - Stanford, CA) |
![]() |
| Dr. David J. Calkins (Vanderbilt University - Nashville, TN) |
Dr. Diana Do, Professor of Ophthalmology and Vice Chair For Clinical Affairs, Byers Eye Institute, Stanford University, discusses the first FDA approved treatment, Encelto, for MacTel (macular telangiectasia), which causes central vision loss.
Dr. David J. Calkins, Denis O'Day Professor, Vice Chair For Strategy, Vice President For Research, Vanderbilt University Medical Center (VUMC), Director of Vanderbilt Vision Research Center (VVRC), talks about the renewal of the NIH grant for Vanderbilt Vision Research Center, its mission, and its current projects.
11/9/2025 Podcast (Click Image Below)
















